arrow
返回
J

Joyce O’Shaughnessy

medical oncology, baylor university medical center, texas oncology, sarah cannon research institute , dallas, tx,

61H指数
452论文数
2.6W被引数
收录论文 131
发表时间
A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2-Positive Metastatic Breast CancerIbrutinib联合曲妥珠单抗治疗HER2阳性转移性乳腺癌的I/II期研究
err2026-09-14
err0
errOAAI
errJoyce O'Shaughnessy; Andrea Glidden; Tracy Locke; Amy Scales; Elizabeth Gatewood; Jean-Philippe Blanck; Jessica Castaneda-Gill; Sharlin Patel; Yolanda D. Mahnke; Xuan Wang; Page Blas
err分享
err收藏
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者报告结局与定性访谈:来自III期EMBER-3试验的结果
err2026-04-09
err0
errOAAI
errG. Curigliano; J. O’Shaughnessy; F.-C. Bidard; M.L. Casalnuovo; S.-B. Kim; E. Tokunaga; P. Aftimos; C. Saura; L.A. Carey; M. Okera; E. Melo; F. Zagouri; M. Magallanes-Maciel; N. Karadurmus; S. Bahadur; R.M. Speck; X.A. Wang; K. Pradhan; J. Macey; H. Kitchen
err分享
err收藏
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02Tucatinib和trastuzumab emtansine用于既往治疗过的HER2阳性局部晚期和转移性乳腺癌患者:随机III期试验HER2CLIMB-02的主要分析
err2025-11-17
err0
errOAAI
errS.A. Hurvitz; S. Loi; J. O’Shaughnessy; A.F.C. Okines; S.M. Tolaney; J. Sohn; C. Saura; X. Zhu; D. Cameron; T. Bachelot; E. Hamilton; G. Curigliano; A.C. Wolff; N. Harbeck; N. Masuda; L. Vahdat; K. Zaman; F. Valdes-Albini; M. Block; T. Pluard
err分享
err收藏
Corrigendum to “Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”勘误:“Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”
err2025-10-15
err0
errOAAI
errM.P. Goetz; M. Toi; J. Huober; J. Sohn; O. Trédan; I.H. Park; M. Campone; S.-C. Chen; L.M. Manso; S. Paluch-Shimon; O.C. Freedman; J. O’Shaughnessy; X. Pivot; S.M. Tolaney; S.A. Hurvitz; A. Llombart-Cussac; V. André; A. Saha; G. van Hal; A. Shahir; H. Iwata; S.R.D. Johnston
err分享
err收藏
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world dataMammaPrint预测HR+HER2-早期乳腺癌的化疗获益:FLEX登记研究真实世界数据
err2025-08-11
err0
errOAAI
errAdam M Brufsky; Kent F Hoskins; Henry J Conter; Pond Kelemen; Mehran Habibi; Laila Samian; Rakshanda L Rahman; Laura Lee; Eduardo C Dias; Regina Hampton; Beth A Sieling; Cynthia R Osborne; Eric Brown; Jailan A Elayoubi; Priyanka Sharma; Jayanthi Ramadurai; Laurie Matt-Amaral; Alfredo A Santillan; Sasha Davis; Philip Albaneze; Harshini Ramaswamy; Nicole Chmielewski-Stivers; Andrea Menicucci; William Audeh; Pat Whitworth; Nathalie Johnson; Joyce O’Shaughnessy
err分享
err收藏
err分享
err收藏
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT studyASCENT研究中,体重指数与转移性三阴性乳腺癌患者中sacituzumab govitecan的安全性和有效性之间的关联
err2025-06-01
err0
errOAAI
errL. García-Estévez; A. Bardia; H.S. Rugo; L.A. Carey; V.C. Diéras; S. Loibl; M. Piccart; L. Gianni; K. Kalinsky; J. O’Shaughnessy; S.A. Hurvitz; E. Harting; T. Valdez; S. Phan; C. Lai; J. Cortés
err分享
err收藏
Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2-early breast cancer真实世界中HR+/HER2-早期乳腺癌患者接受辅助内分泌治疗的复发风险和治疗结局
errBREAST
IF7.9
err2025-06-01
err0
errOAAI
errO'Shaughnessy, Joyce; Tolaney, Sara M.; Yardley, Denise A.; Hart, Lowell; Razavi, Pedram; Fasching, Peter A.; Janni, Wolfgang; Schwartzberg, Lee; Kim, Julia; Akdere, Murat; McDermott, Courtney; Khakwani, Aamir; Pathak, Purnima; Graff, Stephanie L.
err分享
err收藏
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy二线化疗进展后的转移性三阴性乳腺癌患者中Imprime与Pembrolizumab免疫疗法的二期临床试验
err2025-05-08
err0
PREAI
errStopeck, Alison T.; Abu-Khalaf, Maysa; Borges, Virginia; Chmielowski, Bartosz; Rao, Ruta; Xie, Bin; Dudek, Arkadiusz Z.; Mina, Lida; O'Shaughnessy, Joyce; Chisamore, Michael; Mattson, Paulette; Gargano, Michele; Cox, Joanna; Osterwalder, Bruno; Drees, Jeremy; Harrison, Ben; Chan, Anissa S. H.; Qiu, Xiaohong; Ottoson, Nadine; Bose, Nandita; Uhlik, Mark; Graff, Jeremy; Iglesias, Jose
err分享
err收藏
Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II StudyPHranceSCa研究中,HER2阳性早期乳腺癌患者皮下注射固定剂量组合的帕妥珠单抗和曲妥珠单抗的长期安全性与有效性:一项随机、开放标签的II期研究
err2025-05-03
err0
PREAI
errJoyce O'Shaughnessy; Susana Sousa; Josefina Cruz; Dame Lesley Fallowfield; Päivi Auvinen; Catarina Pulido; Ana Cvetanovic; Sharon Wilks; Leonor Ribeiro; Mauricio Burotto; Thomas Boulet; Valentine Revelant; Nathalie Theron; Peter Trask; Laurentia Wahyudi; Zuzana Kirchmayer Machackova; Ljiljana Stamatovic
err分享
err收藏
Impact of Dose Reductions on Efficacy of Adjuvant Abemaciclib for Patients with High Risk Early Breast Cancer: Analyses from the monarchE Study剂量减少对高危早期乳腺癌患者辅助阿贝西利(abemaciclib)疗效的影响:monarchE研究分析
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errAndre, V.; O'Shaughnessy, J.; Cicin, I.; Testa, L.; Tolaney, S.; Huober, J.; Guarneri, V.; Johnston, S.; Martin, M.; Rastogi, P.; Harbeck, N.; Rugo, H.; Wei, R.; Shahir, A.; Goetz, M.
err分享
err收藏
Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine-Biology Is Still King精准医学时代T3肿瘤的新辅助化疗——生物学仍是主宰
err2025-01-09
err0
errOAAI
errRahman, Rakhshanda Layeequr; Santillan, Alfredo; Habibi, Mehran; Beitsch, Peter; Whitworth, Pat; Ramaswamy, Harshini; Chmielewski-Stivers, Nicole; Menicucci, Andrea; Audeh, William; O'Shaughnessy, Joyce
err分享
err收藏
Characteristics of real-world (RW) NATALEE and monarchE eligible populations: A US electronic health records (EHR) database analysis真实世界(RW)NATALEE和monarchE合格人群的特征:一项美国电子健康记录(EHR)数据库分析
err2024-09-01
err1
PREAI
errTarantino, P.; Rugo, H. S.; Curigliano, G.; O'Shaughnessy, J.; Janni, W.; Jhaveri, K.; Mouabbi, J. A.; Brufsky, A. M.; Hamilton, E. P.; ORegan, R.; Santarsiero, E. C.; Sum, E.; Scotchmer, A.; Ye, F.; Graff, S.
err分享
err收藏
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HRD, HER2L advanced breast cancer: final overall survival results of MONARCH 3
err2024-08-01
err17
errOAAI
errGoetz, M. P.; Toi, M.; Huober, J.; Sohn, J.; Tredan, O.; Park, I. H.; Campone, M.; Chen, S. -C.; Manso, L. M.; Paluch-Shimon, S.; Freedman, O. C.; O'Shaughnessy, J.; Pivot, X.; Tolaney, S. M.; Hurvitz, S. A.; Llombart-Cussac, A.; Andre, V.; Saha, A.; van Hal, G.; Shahir, A.; Iwata, H.; Johnston, S. R. D.
err分享
err收藏
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study
err2024-06-24
err3
errOAAI
errDent, Rebecca; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Haiderali, Amin; Jia, Liyi; Nguyen, Allison Martin; Pan, Wilbur; O'Shaughnessy, Joyce; Schmid, Peter
err分享
err收藏
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 8, 98, 2022)sacituzumab govitecan治疗转移性三阴性乳腺癌的3期ASCENT试验的安全性分析 (第8、98、2022卷)
err2024-06-06
err0
errOAAI
errRugo, Hope S.; Tolaney, Sara M.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara A.; O'Shaughnessy, Joyce; Cortes, Javier; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Piccart, Martine J.; Loibl, Sibylle; Goldenberg, David M.; Hong, Quan; Olivo, Martin; Itri, Loretta M.; Kalinsky, Kevin
err分享
err收藏
Phase 1 dose escalation study of ARX788, a next-generation anti-HER2 antibody drug conjugate, in heavily pretreated breast cancer patients
err2024-05-02
err0
PREAI
errFrentzas, Sophia; Park, Haesong; Budd, George; Ganju, Vinod; Shannon, Catherine; Hurvitz, Sara; Cuff, Katharine; Lau, Peter; Eek, Richard; O'Shaughnessy, Joyce; Boyle, Fran; Aung, Sandra; Hessel, Colin; Lu, Janice
err分享
err收藏